RxDoctor Payments Data

Adam Bisaga

Addiction Psychiatry · Ardsley, NYNPI 1023135613

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $7,975 of the $9,269 with a category attached, or 86.0%. Eli Lilly accounts for 89.7% of it on its own, with 5 other manufacturers making up the rest. 2025 is the largest year on record at $8,580, more than ten times the $97 reported in 2022. Among addiction psychiatry clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,269in general payments, 2019–2025

Across 13 payments — averaging $713.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$8K
  • Braeburn Inc.$543
  • Alkermes, Inc.$120
  • Indivior Inc.$106
  • Corium, LLC$97
  • AbbVie$88
$1,027,841in research payments, 2019–2025

Across 13 payments — averaging $79,065 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Alkermes, Inc.$1M

What the payments were for

  • Consulting fees$7,97586%
  • Travel & lodging$2953%
  • Food & beverage$1,00011%

General payments by program year

22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eli Lilly4$8,315
Braeburn Inc.5$543
Alkermes, Inc.1$120
Indivior Inc.1$106
Corium, LLC1$97
AbbVie1$88

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,269 in reported general payments places this provider in the 95th percentile of 43 addiction psychiatry providers in New York.

See all addiction psychiatry providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl13$3,224

Paid to pharmacies, not to this prescriber.

Other addiction psychiatry in Ardsley

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →